Search research articles
Contact Us
Filters
Showing results (261-270 of 289) with videos related to
Page
of 29
Sort By:
The Journal of Vascular Access
|
January 24, 2012
Totally implantable central venous access ports in patients with cystic fibrosis: a multicenter prospective cohort study
Alberto Dal Molin, Dino Stefano Di Massimo, Cesare Braggion, et al.
Plos One
|
December 21, 2019
Assessing gastro-intestinal related quality of life in cystic fibrosis: Validation of PedsQL GI in children and their parents
Mieke Boon, Ine Claes, Trudy Havermans, et al.
European Journal of Cancer (Oxford, England : 1990)
|
December 3, 2019
BRAF V600E status may facilitate decision-making on active surveillance of low-risk papillary thyroid microcarcinoma
Kyeong J Kim, Sin G Kim, Jie Tan, et al.
Frontiers in Immunology
|
May 29, 2019
Genetic Polymorphisms Affecting IDO1 or IDO2 Activity Differently Associate With Aspergillosis in Humans
Valerio Napolioni, Marilena Pariano, Monica Borghi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 3, 2018
BRAF V600E Confers Male Sex Disease-Specific Mortality Risk in Patients With Papillary Thyroid Cancer
Fei Wang, Shihua Zhao, Xiaopei Shen, et al.
Clinical Chemistry and Laboratory Medicine
|
November 17, 2010
A polymorphism in the 5' UTR of the DEFB1 gene is associated with the lung phenotype in F508del homozygous Italian cystic fibrosis patients
Sergio Crovella, Ludovica Segat, Annalisa Amato, et al.
Journal of the National Cancer Institute
|
November 23, 2017
BRAF V600E Mutation-Assisted Risk Stratification of Solitary Intrathyroidal Papillary Thyroid Cancer for Precision Treatment
Yueye Huang, Shen Qu, Guangwu Zhu, et al.
Pediatric Pulmonology
|
February 4, 2025
SHIFTing goals in cystic fibrosis-managing extrapulmonary disease in the era of CFTR modulator therapy; Proceedings of the International Shaping Initiatives and Future Trends (SHIFT) Symposium
Jonathan E M O'Donnell, Lucy A Hastings, Julie N Briody, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society
|
September 12, 2013
Evaluation of specific immune response in early P. aeruginosa infection in cystic fibrosis patients
Daniela Dolce, Lisa Cariani, Silvia Campana, et al.
The New England Journal of Medicine
|
August 26, 2021
Triple Therapy for Cystic Fibrosis <i>Phe508del</i>-Gating and -Residual Function Genotypes
Peter J Barry, Marcus A Mall, Antonio Álvarez, et al.
Page
of 29
Search research articles
Search
Showing results (261-270 of 289) with videos related to
Sort By:
Page
of 29
The Journal of Vascular Access
|
January 24, 2012
Totally implantable central venous access ports in patients with cystic fibrosis: a multicenter prospective cohort study
Alberto Dal Molin, Dino Stefano Di Massimo, Cesare Braggion, et al.
Plos One
|
December 21, 2019
Assessing gastro-intestinal related quality of life in cystic fibrosis: Validation of PedsQL GI in children and their parents
Mieke Boon, Ine Claes, Trudy Havermans, et al.
European Journal of Cancer (Oxford, England : 1990)
|
December 3, 2019
BRAF V600E status may facilitate decision-making on active surveillance of low-risk papillary thyroid microcarcinoma
Kyeong J Kim, Sin G Kim, Jie Tan, et al.
Frontiers in Immunology
|
May 29, 2019
Genetic Polymorphisms Affecting IDO1 or IDO2 Activity Differently Associate With Aspergillosis in Humans
Valerio Napolioni, Marilena Pariano, Monica Borghi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 3, 2018
BRAF V600E Confers Male Sex Disease-Specific Mortality Risk in Patients With Papillary Thyroid Cancer
Fei Wang, Shihua Zhao, Xiaopei Shen, et al.
Clinical Chemistry and Laboratory Medicine
|
November 17, 2010
A polymorphism in the 5' UTR of the DEFB1 gene is associated with the lung phenotype in F508del homozygous Italian cystic fibrosis patients
Sergio Crovella, Ludovica Segat, Annalisa Amato, et al.
Journal of the National Cancer Institute
|
November 23, 2017
BRAF V600E Mutation-Assisted Risk Stratification of Solitary Intrathyroidal Papillary Thyroid Cancer for Precision Treatment
Yueye Huang, Shen Qu, Guangwu Zhu, et al.
Pediatric Pulmonology
|
February 4, 2025
SHIFTing goals in cystic fibrosis-managing extrapulmonary disease in the era of CFTR modulator therapy; Proceedings of the International Shaping Initiatives and Future Trends (SHIFT) Symposium
Jonathan E M O'Donnell, Lucy A Hastings, Julie N Briody, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society
|
September 12, 2013
Evaluation of specific immune response in early P. aeruginosa infection in cystic fibrosis patients
Daniela Dolce, Lisa Cariani, Silvia Campana, et al.
The New England Journal of Medicine
|
August 26, 2021
Triple Therapy for Cystic Fibrosis <i>Phe508del</i>-Gating and -Residual Function Genotypes
Peter J Barry, Marcus A Mall, Antonio Álvarez, et al.
Page
of 29